Sai Life Sciences Discloses FY26 Key Performance Indicators

Sai Life Sciences discloses audited Key Performance Indicators for FY24, FY25, and H1 FY26 as per SEBI ICDR Regulations.
Revenue grew 15.66% YoY to ₹16,945.70 million in H1 FY26, with EBITDA margin expanding to 25.06%.
Profitability improved significantly with PAT reaching ₹1,701.27 million in H1 FY26 and ROCE strengthening to 12.25%.
Operational efficiency enhanced with inventory days reducing to 81 and scientific staff increasing to 2,606.